What is a pulmonary hamartoma (lung hamartoma)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lung hamartomas are benign tumors that do not require further CT follow-up if they are smoothly marginated with internal fat and calcification, as evidenced by the 2017 Fleischner Society guidelines 1. When a lung hamartoma is identified, it is essential to consider its characteristics, such as size, location, and composition.

  • Most lung hamartomas are small, well-circumscribed, and peripheral, appearing as solitary pulmonary nodules on chest imaging.
  • They typically contain a mixture of tissues, including cartilage, fat, fibrous tissue, and sometimes bone.
  • The presence of internal fat and calcification on CT images is highly suggestive of a hamartoma, as seen in Figure 1 of the 2017 Fleischner Society guidelines 1.
  • For asymptomatic lung hamartomas with characteristic features, no further CT follow-up is recommended, according to the guidelines 1.
  • However, larger hamartomas or those causing symptoms may require surgical removal, usually through a minimally invasive approach like video-assisted thoracoscopic surgery (VATS).
  • Regular follow-up imaging may be advised for small, asymptomatic hamartomas to monitor for growth, although the risk of malignant transformation is very low.
  • Lung hamartomas are more common in adults, particularly between ages 40-70, and occur more frequently in men than women, representing about 8% of all solitary pulmonary nodules 1.

From the Research

Definition and Diagnosis of Lung Hamartoma

  • Lung hamartoma is the most common benign tumor of the lung, often presented as a solitary pulmonary nodule of peripheral localization 2, 3.
  • Diagnosis can be achieved through computed tomography (CT) scan, bronchoscopy, and histopathological examination 2, 4.

Treatment Options for Lung Hamartoma

  • Surgical resection is a common treatment option, with methods including tumor enucleation, wedge resection, and lobectomy 3, 5.
  • Video-assisted thoracic surgery (VATS) is a recommended approach for patients with pulmonary hamartoma that cannot be confirmed preoperatively 5.
  • Endoscopic cryosurgical resection is also a viable treatment option for endobronchial hamartoma 4.
  • Complete resection of the tumor is curative, with no tumor recurrence reported in most cases 3, 5.

Clinical Presentation and Outcomes

  • Patients with lung hamartoma may be asymptomatic or present with respiratory symptoms such as cough and dyspnea 3.
  • The majority of pulmonary hamartomas are solitary and can be treated with minimal morbidity 3.
  • Postoperative follow-up has shown no regional recurrence in most cases 5.
  • Rare cases of concomitant giant pulmonary bulla and hamartoma have been reported, with successful treatment through VATS pulmonary wedge resection 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lung hamartoma--diagnosis and treatment.

Medical archives (Sarajevo, Bosnia and Herzegovina), 2012

Research

Pulmonary hamartoma.

Journal of the Chinese Medical Association : JCMA, 2004

Research

Endoscopic cryosurgical resection of pulmonary hamartoma with flexible bronchoscopy.

The Korean journal of thoracic and cardiovascular surgery, 2011

Research

Outcomes of surgical treatments of pulmonary hamartoma.

Journal of cancer research and therapeutics, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.